Healthcare Reform: Employers and Narrow Networks Could Drive Cost-Effective Patient Outcomes
Employers and Medicare trustees could come together and change the healthcare industry, leading to healthcare reform, according to Luke Hansen, M.D., M.H.S., and chief medical officer of Arcadia, a healthcare data analytics company.
Luke Hansen, M.D., M.H.S., chief medical officer of Arcadia, a healthcare data analytics company, said that healthcare reform won’t be easy, specifically when it comes to stronger incentives for value-based care.
Luke Hansen, M.D., M.H.S.
“There are many people in their 40s, 50s, 60s—commercially insured with chronic disease—and their employers are holding the bag, and their employers have a fiduciary responsibility to manage those lives optimally,” Hansen said. “I don't think that we've totally taken advantage of that opportunity. If a large enough cohort of employers came together, they could move the industry, and they could by delegating through narrow networks to high performance provider organizations.”
He continued by explaining that change requires risk.
“You have to be willing to take some risks with constituencies,” Hansen said during a video interview with Managed Healthcare Executive. “I think it starts with attribution and responsibility for cost, which isn’t present in the majority of people administering healthcare.”
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
A Conversation with Jeremiah Johnson, Executive Director of PrEP4All
July 25th 2025Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the importance of preexposure anaphylaxis and why he’s hesitant to jump on the Lenacapavir breakthrough bandwagon.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More
